バイオ医薬品のサードパーティロジスティクス市場：サプライチェーン、サービスタイプ別-2025-2030年の世界予測

バイオ医薬品のサードパーティロジスティクス市場は、2023年に1,070億8,000万米ドルと評価され、2024年には1,217億7,000万米ドルに達すると予測され、CAGR 14.20％で成長し、2030年には2,713億2,000万米ドルに達すると予測されています。

バイオ医薬品のサードパーティロジスティクス（3PL）市場は、バイオ医薬品を効率的に管理・流通させる上で重要な役割を担っており、温度や時間に敏感な医薬品に合わせた倉庫保管、輸送、ロジスティクス技術など、エンドツーエンドのサービスを提供しています。これらのサービスの必要性は、世界な医薬品サプライチェーンの複雑化と、高価値の生物製剤の安全かつ効率的な配送を確保しながら厳格な規制基準を遵守する必要性によってもたらされています。用途は、病院、専門クリニック、薬局など様々な最終用途部門にまたがり、ワクチン、モノクローナル抗体、その他のバイオ医薬品の流通を促進しています。この市場の成長は、特殊医薬品に対する需要の高まり、ロジスティクス技術（リアルタイムモニタリングのためのIoTやAIなど）の進歩、バイオ医薬品生産能力の拡大によって促進されています。新たなビジネスチャンスは、サプライチェーンの透明性とセキュリティを強化するためのブロックチェーンの統合にあり、これは業界がリスクの軽減とコンプライアンスの向上を目指す中でますます魅力的になっています。しかし、専門的なインフラが必要なため運用コストが高いことや、さまざまな地域で絶えず進化する規制を乗り越えることに伴う複雑さなどの制約があります。さらに、多くのバイオ医薬品はニッチな性質を持っているため、個別の保管・輸送ソリューションが必要となり、拡張性は依然として課題となっています。イノベーションは、カーボンフットプリントの削減を目指した持続可能なロジスティクス・ソリューション、適応性のあるコールドチェーン・ソリューションの開発、予測的ロジスティクス・プランニングのためのデータ分析能力の強化に焦点を当てるべきです。市場は本質的に競争的であり、物流プロバイダーと物流ネットワークの最適化を目指すバイオ医薬品企業との戦略的提携や合併が特徴です。利害関係者は、業務効率とサービスの差別化を向上させるためのテクノロジー主導型ソリューションへの投資を優先する一方で、医薬品ニーズが高まる新興市場を開拓するための地域拡大戦略にも注力すべきです。

市場力学：急速に進化するバイオ医薬品のサードパーティロジスティクス市場の主要市場インサイトを公開

バイオ医薬品のサードパーティロジスティクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬・バイオ医薬品業界の研究開発（R&D）支出の増加
  • 生物製剤を輸送するための温度管理された物流サービスに対するニーズの高まり
  • 様々な医療機関による物流のアウトソーシング傾向の台頭
• 市場抑制要因
  • 医薬品開発および創薬手続きのコスト高
• 市場機会
  • バイオ医薬品のサードパーティロジスティクスソリューションにおける技術進歩の高まり
  • バイオシミラー医薬品のニーズの急増
• 市場の課題
  • 国際物流手続きに関する政府の厳しい規則や規制

ポーターの5つの力：バイオ医薬品のサードパーティロジスティクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオ医薬品のサードパーティロジスティクス市場における外部からの影響の把握

外部マクロ環境要因は、バイオ医薬品のサードパーティロジスティクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオ医薬品のサードパーティロジスティクス市場における競合情勢の把握

バイオ医薬品のサードパーティロジスティクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオ医薬品のサードパーティロジスティクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオ医薬品のサードパーティロジスティクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオ医薬品のサードパーティロジスティクス市場における成功への道筋を描く

バイオ医薬品のサードパーティロジスティクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬・バイオ医薬品業界の研究開発費の増加
    • 生物製剤の輸送における温度管理物流サービスの必要性の高まり
    • さまざまな医療機関による物流アウトソーシングの新たな潮流
  • 抑制要因
    • 医薬品開発および医薬品発見手順にかかる高コスト
  • 機会
    • バイオ医薬品のサードパーティロジスティクスソリューションにおける技術進歩の拡大
    • バイオシミラー医薬品の需要が急増
  • 課題
    • 国際物流手続きに関する厳格な政府の規則と規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオ医薬品のサードパーティロジスティクス市場サプライチェーン

• コールドチェーン
• 非コールドチェーン

第7章 バイオ医薬品のサードパーティロジスティクス市場：サービスタイプ別

• 交通機関
  • 航空貨物
  • 陸路
  • 海上輸送
• 倉庫保管

第8章 南北アメリカのバイオ医薬品のサードパーティロジスティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のバイオ医薬品のサードパーティロジスティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイオ医薬品のサードパーティロジスティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agility Public Warehousing Company K.S.C.P
• AmerisourceBergen Corporation
• C.H. Robinson Worldwide, Inc.
• CEVA Logistics AG
• DB Schenker
• DHL International GmbH
• FedEx Corporation
• Hitachi Transport System, Ltd.
• Kerry Logistics Network Ltd.
• Kuehne+Nagel International AG
• McKesson Corporation
• Nippon Express Co., Ltd.
• Schenker AG
• Schneider National, Inc.
• SF Express Co., Ltd.
• United Parcel Service of America, Inc.
• XPO Logistics, Inc.

LIST OF FIGURES

• FIGURE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET RESEARCH PROCESS
• FIGURE 2. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY NON-COLD CHAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY OVERLAND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY WAREHOUSING & STORAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 44. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 47. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 99. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 111. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 114. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SUPPLY CHAIN, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SIZE, BY TRANSPORTATION, 2018-2030 (USD MILLION)
• TABLE 144. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. BIOPHARMACEUTICAL THIRD PARTY LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Biopharmaceutical Third Party Logistics Market was valued at USD 107.08 billion in 2023, expected to reach USD 121.77 billion in 2024, and is projected to grow at a CAGR of 14.20%, to USD 271.32 billion by 2030.

The biopharmaceutical third-party logistics (3PL) market plays a crucial role in efficiently managing and distributing biopharmaceutical products, providing end-to-end services including warehousing, transportation, and logistics technology tailored for temperature-sensitive and time-critical pharmaceuticals. The necessity of these services is driven by the increasing complexity of the global pharmaceutical supply chain and the need to adhere to stringent regulatory standards while ensuring the safe and efficient delivery of high-value biologics. Applications span across various end-use sectors including hospitals, specialized clinics, and pharmacies, facilitating the distribution of vaccines, monoclonal antibodies, and other biotech drugs. Growth in this market is being fueled by the rising demand for specialty medicines, advancements in logistics technology (like IoT and AI for real-time monitoring), and the expansion of biopharmaceutical production capacities. An emerging opportunity lies in the integration of blockchain for enhanced transparency and security in supply chains, which is increasingly appealing as the industry seeks to mitigate risk and improve compliance. However, the market faces limitations such as high operational costs due to the need for specialized infrastructure and the complexities associated with navigating constantly evolving regulations across different territories. Furthermore, scalability remains challenging due to the niche nature of many biopharmaceuticals requiring tailored storage and transport solutions. Innovation should focus on sustainable logistics solutions aimed at reducing carbon footprint, developing adaptive cold chain solutions, and enhancing data analytics capabilities for predictive logistics planning. The market is inherently competitive, characterized by strategic collaborations and mergers among logistics providers and biopharma companies seeking to optimize distribution networks. Stakeholders should prioritize investments in technology-driven solutions to improve operational efficiency and service differentiation, while also focusing on regional expansion strategies to tap into emerging markets with growing pharmaceutical needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Third Party Logistics Market

The Biopharmaceutical Third Party Logistics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
  • Rising need for temperature-controlled logistic services to transport biologics
  • Emerging trend of outsourcing logistics by various medical organizations
• Market Restraints
  • High costs of drug development and drug discovery procedures
• Market Opportunities
  • Growing technological advancements in biopharmaceutical third party logistics solutions
  • Rapidly growing need for the biosimilar medicines
• Market Challenges
  • Stringent governmental rules and regulations for international logistics procedures

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Third Party Logistics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Third Party Logistics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Third Party Logistics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Third Party Logistics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Third Party Logistics Market

A detailed market share analysis in the Biopharmaceutical Third Party Logistics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Third Party Logistics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Third Party Logistics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biopharmaceutical Third Party Logistics Market

A strategic analysis of the Biopharmaceutical Third Party Logistics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Third Party Logistics Market, highlighting leading vendors and their innovative profiles. These include Agility Public Warehousing Company K.S.C.P, AmerisourceBergen Corporation, C.H. Robinson Worldwide, Inc., CEVA Logistics AG, DB Schenker, DHL International GmbH, FedEx Corporation, Hitachi Transport System, Ltd., Kerry Logistics Network Ltd., Kuehne + Nagel International AG, McKesson Corporation, Nippon Express Co., Ltd., Schenker AG, Schneider National, Inc., SF Express Co., Ltd., United Parcel Service of America, Inc., and XPO Logistics, Inc..

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Third Party Logistics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Supply Chain, market is studied across Cold Chain and Non-Cold Chain.
• Based on Service Type, market is studied across Transportation and Warehousing & Storage. The Transportation is further studied across Air Freight, Overland, and Sea Freight.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing research and development (R&D) expenditure of pharmaceutical and biopharmaceutical industry
    • 5.1.1.2. Rising need for temperature-controlled logistic services to transport biologics
    • 5.1.1.3. Emerging trend of outsourcing logistics by various medical organizations
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of drug development and drug discovery procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing technological advancements in biopharmaceutical third party logistics solutions
    • 5.1.3.2. Rapidly growing need for the biosimilar medicines
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent governmental rules and regulations for international logistics procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biopharmaceutical Third Party Logistics Market, by Supply Chain

• 6.1. Introduction
• 6.2. Cold Chain
• 6.3. Non-Cold Chain

7. Biopharmaceutical Third Party Logistics Market, by Service Type

• 7.1. Introduction
• 7.2. Transportation
  • 7.2.1. Air Freight
  • 7.2.2. Overland
  • 7.2.3. Sea Freight
• 7.3. Warehousing & Storage

8. Americas Biopharmaceutical Third Party Logistics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biopharmaceutical Third Party Logistics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biopharmaceutical Third Party Logistics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agility Public Warehousing Company K.S.C.P
• 2. AmerisourceBergen Corporation
• 3. C.H. Robinson Worldwide, Inc.
• 4. CEVA Logistics AG
• 5. DB Schenker
• 6. DHL International GmbH
• 7. FedEx Corporation
• 8. Hitachi Transport System, Ltd.
• 9. Kerry Logistics Network Ltd.
• 10. Kuehne + Nagel International AG
• 11. McKesson Corporation
• 12. Nippon Express Co., Ltd.
• 13. Schenker AG
• 14. Schneider National, Inc.
• 15. SF Express Co., Ltd.
• 16. United Parcel Service of America, Inc.
• 17. XPO Logistics, Inc.